| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 10/18/2006 | CN1280417C Human tyrosinase expression carrier and its use |
| 10/18/2006 | CN1280410C Cholera vibrio strain |
| 10/18/2006 | CN1280409C Health protecting product composition with liver protecting and blood fat regulating function and its preparation |
| 10/18/2006 | CN1280408C Self floculation hydrogen producing bacteria and its sieving method |
| 10/18/2006 | CN1280407C Lactobacillus pentosus strain, ferment produced thereby and the use of ferment in meat ware |
| 10/18/2006 | CN1280406C Biologic bactericide for preventing and curing disease of garden of spgarden stuff after picking, and specific strain |
| 10/18/2006 | CN1280405C Method of increasing hydrogen releasing efficient of chlamydomonas |
| 10/18/2006 | CN1280404C Method of observing single microbial cell |
| 10/18/2006 | CN1280310C Fusion protein with cold proventing and curing function and its encoding gene and use |
| 10/18/2006 | CN1280249C Tricyclopolyketone compound preparation method and application |
| 10/18/2006 | CN1279977C Peptide-based fluorescence polarization assay for detection of antibodies to mycobacterium bovis |
| 10/18/2006 | CN1279971C Novel method for down-regulation of amyloid |
| 10/18/2006 | CN1279906C Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 10/18/2006 | CN1279890C Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases |
| 10/17/2006 | USRE39355 Fusion protein with amino acid sequence of mature human insulin-like growth factor; synthesized in recombinant cell culture by host cells transformed with expression vectors; genetic engineering |
| 10/17/2006 | USRE39352 Creatine amidinohydrolase, production thereof and use thereof |
| 10/17/2006 | USRE39350 RNA binding protein and binding site useful for expression of recombinant molecules |
| 10/17/2006 | US7122717 Comprises nucleotide seqences coding cycloartenol synthase and squalene monooxygenase for transformation of plants and enhancing terpenoid biosynthesis |
| 10/17/2006 | US7122654 Hybrid; adjust vascular system permeability |
| 10/17/2006 | US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene |
| 10/17/2006 | US7122650 Comprises nucleotide sequences coding polypeptide which inactivates corticotropin-releasing factor (CRF) for use as to in treatment of anxiety and depression |
| 10/17/2006 | US7122630 Proteins in cell cycle regulation; cell cycle protein binds to SYK kinase |
| 10/17/2006 | US7122520 Nucleotide sequences coding polypeptide for use in the eating disorders |
| 10/17/2006 | US7122516 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics |
| 10/17/2006 | US7122373 Human genes and gene expression products V |
| 10/17/2006 | US7122370 Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
| 10/17/2006 | US7122369 Corynebacterium, Brevibacterium; culture product |
| 10/17/2006 | US7122368 Point mutations; recombinant vectors/molecular targets; transcription factors |
| 10/17/2006 | US7122367 Can be used to transform oil crop plants |
| 10/17/2006 | US7122363 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics |
| 10/17/2006 | US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases |
| 10/17/2006 | US7122361 Compositions employing a novel human kinase |
| 10/17/2006 | US7122360 Polypeptides, polynucleotides and uses thereof |
| 10/17/2006 | US7122358 Testis-specific tubulin tyrosine-ligase-like protein, BGS42 |
| 10/17/2006 | US7122353 For use in cancer therapy |
| 10/17/2006 | US7122351 Dimerized PDGF-D and materials and methods for producing it |
| 10/17/2006 | US7122350 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex |
| 10/17/2006 | US7122347 A chimeric Arterivirus composed of parts originating from at least two different arteriviruses where a stretch of nucleic acids encoding a non-Arteriviris protein fragment is inserted in the full genome; vaccines; veterinary medicine; swine |
| 10/17/2006 | US7122346 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies |
| 10/17/2006 | US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled |
| 10/17/2006 | US7122341 Engineering of metabolic control |
| 10/17/2006 | US7122337 Method for determining calciotropic activity of a preparation of Padina pavonic algae |
| 10/17/2006 | US7122305 Methods and compositions for identifying receptor effectors |
| 10/17/2006 | US7122304 Methods for the storage and synthesis of nucleic acids using a solid support |
| 10/17/2006 | US7122302 Method for determining early HCV seroconversion |
| 10/17/2006 | US7122197 Compounds from Moraxella catarrhalis |
| 10/17/2006 | US7122196 Compounds and methods for diagnosis of tuberculosis |
| 10/17/2006 | US7122195 Mutant mycobacteria for use in therapy |
| 10/17/2006 | US7122180 DNA vectors containing mutated HIV proviruses |
| 10/17/2006 | CA2271930C Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof |
| 10/12/2006 | WO2006108139A2 Generation of materials with enhanced hydrogen content from microbial consortia including thermotoga |
| 10/12/2006 | WO2006108138A2 Systems and methods for the isolation and identification of microorganisms from hydrocarbon deposits |
| 10/12/2006 | WO2006108136A2 Generation of materials with enhanced hydrogen content from anaerobic microbial consortia |
| 10/12/2006 | WO2006107127A1 Method for improving a strain based on in-silico analysis |
| 10/12/2006 | WO2006107084A1 Yeast mutant strain capable of producing secreted thermostable enzyme in high secretion level |
| 10/12/2006 | WO2006106912A1 Cancer-associated antigen analog peptide and utilization of the same |
| 10/12/2006 | WO2006106905A1 Process for production of polypeptide by regulation of assembly |
| 10/12/2006 | WO2006106806A1 Method for improvement of storage stability of dried microorganism |
| 10/12/2006 | WO2006106678A1 Boron absorption-promoting gene |
| 10/12/2006 | WO2006106166A1 Attenuated live strain of staphylococcus aureus as a vaccine against bovine mastitis |
| 10/12/2006 | WO2006087637A3 Anti her2/neu antibody |
| 10/12/2006 | WO2006087405A3 Novel microalgal species and use thereof for animal and/or human consumption and in the production of carotenoids |
| 10/12/2006 | WO2006065137A3 Novel efficient production process for capsular polysaccharides of pathogenic grampositive bacteria by heterologous expression and secretion of complex polysaccharides in non-pathogenic, non-invasive gram- positive bacteria |
| 10/12/2006 | WO2006052826A3 Methods for preparing cells and viruses |
| 10/12/2006 | WO2005105978A3 Drying process for preserving an active agent as a highly viscous liquid |
| 10/12/2006 | WO2005089262A3 Novel peanut skin extract as a vaccine adjuvant |
| 10/12/2006 | US20060230467 Plant deoxyribonucleoside kinase enzymes and their use |
| 10/12/2006 | US20060229223 Having specific base substitutions and improved thermostability; controlling pitch troubles in pulping or papermaking; detergents; removing hydrophobic esters from fabrics; catalyst for hydrolysis or synthesis of esters |
| 10/12/2006 | US20060228797 Method for altering the metabolism of plant |
| 10/12/2006 | US20060228792 Microorganism capable of degrading aromatic polyester and method of degrading aromatic polyester using the same |
| 10/12/2006 | US20060228791 Subtilases and subtilase variants having altered immunogenicity |
| 10/12/2006 | US20060228790 L-glutamate oxidase |
| 10/12/2006 | US20060228789 Xylose-fermenting recombinant yeast strains |
| 10/12/2006 | US20060228787 Mutants for the preparation of d-amino acids |
| 10/12/2006 | US20060228785 Recombinant microorganism for the production of vitamin b6 |
| 10/12/2006 | US20060228783 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |
| 10/12/2006 | US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
| 10/12/2006 | US20060228781 Synthetic gene coding for human granulocyte-colony stimulating factor for the expression in e.coli |
| 10/12/2006 | US20060228780 Chromatographic method and system for purifying a botulinum toxin |
| 10/12/2006 | US20060228777 Animal product free media and processes for obtaining a botulinum toxin |
| 10/12/2006 | US20060228774 Oxygen-resistant hydrogenases and methods for designing and making same |
| 10/12/2006 | US20060228763 Periostin-based diagnostic assays |
| 10/12/2006 | US20060228761 Novel RIP3 associated cell cycle proteins, compositions and methods of use |
| 10/12/2006 | US20060228731 Compositions and methods of using a synthetic DNase I |
| 10/12/2006 | US20060228712 Incubating the polynucleotide array with at least one of a labeled polynucleotide derived from a coryneform bacterium, a labeled polynucleotide derived from a mutant of the coryneform bacterium or a labeled polynucleotide,detecting any hybridization, analyzing |
| 10/12/2006 | US20060228446 improved polypeptides by substituting or deleting specified amino acids in fungal lipolytic enzymes; reduction of dough stickiness when they are added to a dough |
| 10/12/2006 | US20060228445 biosynthesis producing vinegar; using the genes of acetobacter to encode a protein involved in shortening the growth promotion and resistance to acetic acid in the presence of a high acetic acid concentration; genetic engineering |
| 10/12/2006 | US20060228381 Separation of contaminants from Streptococcus pneumoniae polysaccharide by pH manipulation |
| 10/12/2006 | US20060228379 Novel microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities |
| 10/12/2006 | US20060228378 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 10/12/2006 | US20060228377 Gram-positive bacteria deprived of HtrA protease activity and their uses |
| 10/12/2006 | US20060228363 Monoclonal antibody therapy for pancreas cancer |
| 10/12/2006 | US20060228353 PTH1R and PTH3R receptors, methods and uses thereof |
| 10/12/2006 | US20060228329 Homogeneous preparations of IL-31 |
| 10/12/2006 | DE4237113B4 Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins Peptides and fusion proteins, expression vector and methods for producing a fusion protein |
| 10/12/2006 | DE102004028356B4 Verfahren und Anlage zum Klimaschutz durch umweltschonende Nettoproduktion von Sauerstoff bei gleichzeitigem Nettoverbrauch von Kohlendioxid unter Verwendung von Mikroalgen Method and apparatus for climate protection through environmentally friendly net production of oxygen at the same time net consumption of carbon dioxide using microalgae |
| 10/12/2006 | CA2603787A1 Generation of materials with enhanced hydrogen content from microbial consortia including thermotoga |
| 10/12/2006 | CA2603755A1 Generation of materials with enhanced hydrogen content from anaerobic microbial consortia |
| 10/12/2006 | CA2603408A1 Process for production of polypeptide by regulation of assembly |
| 10/11/2006 | EP1710582A2 Suppressor genes |